Optinose to Present at the Piper Sandler Virtual Healthcare Conference
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ENT and allergy treatments, announced that CEO Peter Miller will present a company overview at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ENT and allergy treatments, announced that CEO Peter Miller will present a company overview at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. A pre-recorded fireside chat is available on their website, with 1x1 meetings set for November 30. The webcast will be accessible for 30 days post-event. For more information, visit Optinose.
Details
News Market Reaction – OPTN
The recorded move for OPTN in the trading session of this news was +7.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YARDLEY, Pa., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Piper Sandler 33rd Annual Virtual Healthcare Conference scheduled for November 29 through December, 2, 2021.
A pre-recorded fireside chat is available on-demand on the Investors page of the Optinose website. The company will host 1x1 meetings on Tuesday, November 30, 2021. The webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.